Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: preliminary results of the feasibility EPIONE trial
B Hersant, G Werkoff, D Sawan… - Annales de Chirurgie …, 2020 - Elsevier
Background and objective Quality of life preservation after anti-cancer therapy is a major
challenge for breast cancer survivors. Approximately 42–70% of patients who receive …
challenge for breast cancer survivors. Approximately 42–70% of patients who receive …
Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: Preliminary results of the feasibility EPIONE trial
B Hersant, G Werkoff, D Sawan… - ANNALES DE …, 2020 - iris.unina.it
Contexte et objectif: La préservation de la qualité de vie après un traitement anticancéreux
est un défi majeur pour les survivantes du cancer du sein. Environ 42 à 70% des patients …
est un défi majeur pour les survivantes du cancer du sein. Environ 42 à 70% des patients …
Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: Preliminary results of the feasibility EPIONE trial
B Hersant, G Werkoff, D Sawan… - Annales de …, 2020 - pubmed.ncbi.nlm.nih.gov
Background and objective Quality of life preservation after anti-cancer therapy is a major
challenge for breast cancer survivors. Approximately 42-70% of patients who receive …
challenge for breast cancer survivors. Approximately 42-70% of patients who receive …
Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: Preliminary results of the feasibility EPIONE trial.
B Hersant, G Werkoff, D Sawan… - Annales de Chirurgie …, 2020 - europepmc.org
Results The mean age of the patients was 56.1±8.8 years (range, 27-69 years). Seventeen
of the 20 patients had experienced menopause (mean menopausal age, 51.25±1.5 years) …
of the 20 patients had experienced menopause (mean menopausal age, 51.25±1.5 years) …
Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: Preliminary results of the feasibility EPIONE trial
B Hersant, G Werkoff, D Sawan… - Annales de Chirurgie …, 2020 - hal.science
Background and objective: Quality of life preservation after anti-cancer therapy is a major
challenge for breast cancer survivors. Approximately 42-70% of patients who receive …
challenge for breast cancer survivors. Approximately 42-70% of patients who receive …
Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: Preliminary results of the feasibility EPIONE trial
B Hersant, G Werkoff, D Sawan… - Annales de Chirurgie …, 2020 - inria.hal.science
Background and objective: Quality of life preservation after anti-cancer therapy is a major
challenge for breast cancer survivors. Approximately 42-70% of patients who receive …
challenge for breast cancer survivors. Approximately 42-70% of patients who receive …
[PDF][PDF] Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: Preliminary results of the feasibility EPIONE trial
B Hersant, G Werkoff, D Sawan, M Sidahmed-Mezi… - 2020 - hal.science
Abstract Background and Objective: Quality of life preservation after anti-cancer therapy is a
major challenge for breast cancer survivors. Approximately 42–70% of patients who receive …
major challenge for breast cancer survivors. Approximately 42–70% of patients who receive …